Skip to main content
Skip to footer
Home
About us
About us
Leadership Team
Our Science
Therapeutic Focus
News
News & Press Releases
Publications
Contact
Contact
Join the Community
Investors & Partnering
Investors
Partnering
Jobs
Home
About us
About us
Leadership Team
Our Science
Therapeutic Focus
News
News & Press Releases
Publications
Contact
Contact
Join the Community
Investors & Partnering
Investors
Partnering
Jobs
Category:
PR
Mallia Therapeutics Secures Seed Funding for its Novel Topical Treatment to Induce Hair Growth via Immune Modulation
11. July 2023
Erlangen, Germany, July 11, 2023 / Mallia Therapeutics GmbH, a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of…
11. July 2023Erlangen, Germany, July 11, 2023 / Mallia Therapeutics GmbH, a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of…
